Literature DB >> 12780699

Difference in antigenic determinant profiles between human and rat myeloperoxidase.

Y C Patry1, P H Nachman, M A P Audrain, R J Falk, K Meflah, V L M Esnault.   

Abstract

We tested whether rat and human MPO have similar antigenic determinants using 36 human MPO-ANCA positive sera, one mouse anti-rat MPO and four mouse anti-human MPO monoclonal reagents. Purified rat and human MPO were used in ELISA, with or without crossinhibition by preincubation with human MPO or irrelevant antigen in the liquid phase. Only one human MPO ANCA positive serum exhibited significant binding in rat MPO ELISA. This binding was poorly inhibited by preincubation with human MPO in the liquid phase, but was conserved after adsorption of non specific anti-rat activity in a chromatography column. Three mouse anti-human MPO IgG monoclonal antibodies did not recognize rat MPO. Only one mouse anti-human MPO IgA monoclonal antibody bound to rat MPO. This binding was poorly inhibited by preincubation with human MPO (35% at 2 micro g/ml). Conversely, the mouse anti-rat MPO monoclonal did not bind human MPO. We have concluded that: (1) Most human MPO-ANCA recognize antigenic determinants on human MPO which are absent on rat MPO. Therefore, human auto-antibodies bind to epitopes which recently appeared after species evolution; (2) Inversely, the mouse anti-rat MPO monoclonal do not bind human MPO. Therefore, rat MPO epitopes have been altered during species evolution; (3) Mice injected with human MPO preferentially develop antibodies against xeno-epitopes which are not present in rodents. Therefore, human MPO may not be the best antigen to raise ANCA in animal models and (4) A comparison of the amino acid sequences of rat and human MPO may help elucidate the major antigenic epitopes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780699      PMCID: PMC1808723          DOI: 10.1046/j.1365-2249.2003.02175.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.

Authors:  P Heeringa; E Brouwer; P A Klok; M G Huitema; J van den Born; J J Weening; C G Kallenberg
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies.

Authors:  M A Audrain; T A Baranger; N Moguilevski; S J Martin; A Devys; C M Lockwood; J Y Muller; V L Esnault
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

3.  Nucleotide sequence of cDNA for murine myeloperoxidase.

Authors:  D Venturelli; N Shirsat; I Gemperlein; S Bittenbender; S Hudson; G Rovera
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

4.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Authors:  Hong Xiao; Peter Heeringa; Peiqi Hu; Zhi Liu; Minglang Zhao; Yasuaki Aratani; Nobuyo Maeda; Ronald J Falk; J Charles Jennette
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase.

Authors:  J J Yang; J C Jennette; R J Falk
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

7.  Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis.

Authors:  K Kinjoh; M Kyogoku; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

Authors:  C O Savage; B E Pottinger; G Gaskin; C D Pusey; J D Pearson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride.

Authors:  V L Esnault; P W Mathieson; S Thiru; D B Oliveira; C Martin-Lockwood
Journal:  Lab Invest       Date:  1992-07       Impact factor: 5.662

10.  Renal ischemia/reperfusion injury contributes to renal damage in experimental anti-myeloperoxidase-associated proliferative glomerulonephritis.

Authors:  E Brouwer; P A Klok; M G Huitema; J J Weening; C G Kallenberg
Journal:  Kidney Int       Date:  1995-04       Impact factor: 10.612

View more
  4 in total

1.  Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity.

Authors:  F Yu; M-H Zhao; Y-K Zhang; Y Zhang; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes.

Authors:  B F Bruner; E S Vista; D M Wynn; J A James
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

Review 3.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

4.  Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.

Authors:  Mark A Little; Lucy Smyth; Alan D Salama; Sriparna Mukherjee; Jennifer Smith; Dorian Haskard; Sussan Nourshargh; H Terence Cook; Charles D Pusey
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.